199 related articles for article (PubMed ID: 20205290)
1. Transjugular intrahepatic portosystemic shunt with accidental diagnosis of persistence of the left superior vena cava.
Petridis I; Miraglia R; Marrone G; Gruttadauria S; Luca A; Vizzini GB; Gridelli B
World J Gastroenterol; 2010 Mar; 16(9):1158-60. PubMed ID: 20205290
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.
Bettinger D; Knüppel E; Euringer W; Spangenberg HC; Rössle M; Thimme R; Schultheiß M
Aliment Pharmacol Ther; 2015 Jan; 41(1):126-36. PubMed ID: 25329493
[TBL] [Abstract][Full Text] [Related]
3. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease.
Verbeeck S; Mekhali D; Cassiman D; Maleux G; Witters P
Dig Liver Dis; 2018 Jul; 50(7):707-712. PubMed ID: 29622386
[TBL] [Abstract][Full Text] [Related]
5. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites.
Martinet JP; Legault L; Cernacek P; Roy L; Dufresne MP; Spahr L; Fenyves D; Pomier-Layrargues G
J Hepatol; 1996 Nov; 25(5):700-6. PubMed ID: 8938548
[TBL] [Abstract][Full Text] [Related]
6. The transjugular intrahepatic portosystemic shunt (TIPS).
Owen AR; Stanley AJ; Vijayananthan A; Moss JG
Clin Radiol; 2009 Jul; 64(7):664-74. PubMed ID: 19520210
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt placement in a patient with absent right superior vena cava and persistent left superior vena cava.
Bahramipour P; Abu-Judeh HH; Miller J
AJR Am J Roentgenol; 1999 Sep; 173(3):631-2. PubMed ID: 10470892
[No Abstract] [Full Text] [Related]
8. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
Grønbaek H; Astrup LB; Nielsen DT; Vilstrup H
Ugeskr Laeger; 2003 Jan; 165(5):439-42. PubMed ID: 12599838
[TBL] [Abstract][Full Text] [Related]
9. [Clinical results and hemodynamic changes of portal venous system in transjugular intrahepatic portosystemic stent shunt].
Wu X; Cao J; Wu X
Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):303-6. PubMed ID: 9387710
[TBL] [Abstract][Full Text] [Related]
10. Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension-Induced Refractory Ascites Due to Metastatic Carcinomatous Liver Disease.
Geeroms B; De Hertogh G; Vanslembrouck R; Wildiers H; Nevens F; Maleux G
J Vasc Interv Radiol; 2018 Dec; 29(12):1713-1716. PubMed ID: 30392802
[TBL] [Abstract][Full Text] [Related]
11. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
12. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt in cavernomatous portal vein occlusion.
Brountzos EN; Malagari K; Alexopoulou E; Nikolaou VE; Panagiotou I; Argyriou P; Efstathopoulos E; Kelekis DA
Hepatogastroenterology; 2004; 51(58):1168-71. PubMed ID: 15239270
[TBL] [Abstract][Full Text] [Related]
14. Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis.
Lutz P; Strunk H; Schild HH; Sauerbruch T
World J Gastroenterol; 2013 Feb; 19(7):1140-2. PubMed ID: 23467463
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension.
Hosokawa I; Adam R; Allard MA; Pittau G; Vibert E; Cherqui D; Sa Cunha A; Bismuth H; Miyazaki M; Castaing D
Br J Surg; 2017 Mar; 104(4):443-451. PubMed ID: 28079252
[TBL] [Abstract][Full Text] [Related]
16. Portal anatomic variants relevant to transjugular intrahepatic portosystemic shunt.
Saad N; Darcy M; Saad W
Tech Vasc Interv Radiol; 2008 Dec; 11(4):203-7. PubMed ID: 19527845
[TBL] [Abstract][Full Text] [Related]
17. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic stent-shunt (TIPSS): technique and indications.
Kauffmann GW; Richter GM
Eur Radiol; 1999; 9(4):685-92. PubMed ID: 10354885
[No Abstract] [Full Text] [Related]
19. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
Strunk H; Marinova M
Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
[TBL] [Abstract][Full Text] [Related]
20. Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant.
Lenci I; Neri B; Morosetti D; Milana M; Palmieri G; Tisone G; Orlacchio A; Angelico M; Baiocchi L
Ann Hepatol; 2021; 22():100162. PubMed ID: 31862175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
